{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T20:19:14Z","timestamp":1694636354175},"reference-count":18,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,1,1]]},"DOI":"10.2478\/v10039-009-0015-6","type":"journal-article","created":{"date-parts":[[2009,6,9]],"date-time":"2009-06-09T01:08:35Z","timestamp":1244509715000},"source":"Crossref","is-referenced-by-count":3,"title":["Telmisartan lowers albuminuria in type 2 diabetic patients treated with angiotensin enzyme inhibitors"],"prefix":"10.1016","volume":"54","author":[{"given":"M","family":"Mazerska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"My\u015bliwiec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1046\/j.1523-1755.2003.00712.x","article-title":"Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64)","volume":"1","author":"A Adler","year":"2003","journal-title":"Kidney Int"},{"key":"2","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1056\/NEJM199910073411506","article-title":"Nephropathy in patients with type 2 diabetes mellitus","volume":"15","author":"E Ritz","year":"1999","journal-title":"N Engl J Med"},{"key":"3","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0272-6386(96)90538-7","article-title":"Diabetic nephropathy in type II diabetes","volume":"2","author":"E Ritz","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"4","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1681\/ASN.V9122336","article-title":"The nephropathy of non-insulin-dependent diabetes: predictors of outcome relative to diverse patterns of renal injury","volume":"12","author":"P Ruggenenti","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"5","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1681\/ASN.2005010083","article-title":"Type 2 diabetic nephropathy: never too early to treat?","volume":"3","author":"K Hilgers","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"6","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/ki.1989.227","article-title":"Short and long term effects of antihypertensive therapy in the diabetic rat","volume":"4","author":"S Anderson","year":"1989","journal-title":"Kidney Int"},{"key":"7","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1681\/ASN.2004090763","article-title":"Impact of achieved blood pressure on cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial","volume":"7","author":"T Berl","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"8","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"12","author":"B Brenner","year":"2001","journal-title":"N Engl J Med"},{"key":"9","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1056\/NEJMoa042274","article-title":"Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy","volume":"19","author":"A Barnett","year":"2004","journal-title":"N Engl J Med"},{"key":"10","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0272-6386(12)70217-2","article-title":"An overview of renal pathology in insulin-dependent diabetes mellitus in relationship to altered glomerular hemodynamics","volume":"6","author":"P Fioretto","year":"1992","journal-title":"Am J Kidney Dis"},{"key":"11","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1681\/ASN.V4140","article-title":"Shortand long-term effect of angiotensin II aeceptor blockade in rats with experimental diabetes","volume":"1","author":"A Remuzzi","year":"1993","journal-title":"J Am Soc Nephrol"},{"key":"12","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1681\/ASN.2004100852","article-title":"Chronic angiotensin II receptor blockade reduces (intra)renal vascular resistance in patients with type 2 diabetes","volume":"4","author":"D Fliser","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"13","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1046\/j.1523-1755.2003.00832.x","article-title":"Effects of combined ACE inhibitor and angiotensin II antagonist treatment in human chronic nephropathies","volume":"3","author":"R Campbell","year":"2003","journal-title":"Kidney Int"},{"key":"14","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(03)12229-5","article-title":"Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial","volume":"9352","author":"N Nakao","year":"2003","journal-title":"Lancet"},{"key":"15","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1056\/NEJMoa010713","article-title":"A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure","volume":"23","author":"J Cohn","year":"2001","journal-title":"N Engl J Med"},{"key":"16","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0140-6736(03)14283-3","article-title":"Effects of candesartan in patients with chronic heart failure and reduced leftventricular systolic function taking angiotensin-convertingenzyme inhibitors: the CHARM-Added trial","volume":"9386","author":"J McMurray","year":"2003","journal-title":"Lancet"},{"key":"17","doi-asserted-by":"crossref","unstructured":"ONTARGET Investigators, Yusuf S, Teo KK, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P, Anderson C. Telmisartan, ramipril, or both in patients at high risk for vascular events. <i>N Engl J Med.<\/i> 2008 Apr 10;358(15):1547-59. Epub 2008 Mar 31.","DOI":"10.1056\/NEJMoa0801317"},{"key":"18","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0140-6736(08)61236-2","article-title":"Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial","volume":"9638","author":"J Mann","year":"2008","journal-title":"Lancet"}],"container-title":["Advances in Medical Sciences"],"original-title":[],"link":[{"URL":"http:\/\/versita.metapress.com\/index\/K010011171V45060.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T04:34:42Z","timestamp":1633581282000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.degruyter.com\/view\/j\/ams.2009.54.issue-1\/v10039-009-0015-6\/v10039-009-0015-6.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,1]]},"references-count":18,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.2478\/v10039-009-0015-6","relation":{},"ISSN":["1898-4002","1896-1126"],"issn-type":[{"value":"1898-4002","type":"electronic"},{"value":"1896-1126","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1,1]]}}}